IRIS
DIGIACOMO, GRAZIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.571
EU - Europa 1.132
AS - Asia 919
SA - Sud America 203
AF - Africa 53
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.881
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.557
IT - Italia 498
SG - Singapore 385
CN - Cina 318
BR - Brasile 173
IE - Irlanda 154
SE - Svezia 109
DE - Germania 97
HK - Hong Kong 71
NL - Olanda 49
IN - India 38
RU - Federazione Russa 36
ZA - Sudafrica 36
FR - Francia 31
BE - Belgio 29
VN - Vietnam 28
GB - Regno Unito 24
FI - Finlandia 22
AR - Argentina 19
AT - Austria 19
ID - Indonesia 12
CI - Costa d'Avorio 11
KR - Corea 11
TR - Turchia 11
UA - Ucraina 11
PL - Polonia 10
CA - Canada 9
ES - Italia 9
JP - Giappone 9
CZ - Repubblica Ceca 7
LT - Lituania 7
BD - Bangladesh 5
IQ - Iraq 5
RO - Romania 5
UZ - Uzbekistan 5
EC - Ecuador 4
MX - Messico 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
LU - Lussemburgo 3
PY - Paraguay 3
AZ - Azerbaigian 2
CO - Colombia 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
KG - Kirghizistan 2
MK - Macedonia 2
TN - Tunisia 2
AD - Andorra 1
AL - Albania 1
AU - Australia 1
CL - Cile 1
CY - Cipro 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
QA - Qatar 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.881
Salva come PNG Salva come JPEG
Città #
Dallas 262
Ann Arbor 234
Singapore 199
Ashburn 182
Dublin 154
Chandler 148
Parma 123
Santa Clara 99
Hong Kong 71
Beijing 55
Boardman 46
Munich 46
Shanghai 45
Dearborn 42
Milan 41
Hefei 40
Los Angeles 38
Johannesburg 35
New York 33
Chicago 25
Modena 24
Nanjing 21
Princeton 21
Bologna 17
Redmond 17
Reggio Emilia 17
Bremen 16
São Paulo 15
Moscow 14
Vienna 14
Columbus 13
Helsinki 13
Brussels 12
Jakarta 12
Wayne 12
Abidjan 11
Amsterdam 10
Florence 10
Ho Chi Minh City 10
Rome 10
Seoul 10
The Dalles 10
Wilmington 10
Izmir 9
Nuremberg 9
San Mateo 9
Shenyang 9
Turku 9
Warsaw 9
Council Bluffs 8
Des Moines 8
Jinan 8
Verona 8
Woodbridge 8
Bari 7
Binche 7
Frankfurt am Main 7
London 7
Nanchang 7
Seattle 7
Tokyo 7
Chennai 6
Denver 6
Dong Ket 6
Follonica 6
Fremont 6
Houston 6
Leuven 6
Marseille 6
Stockholm 6
Bengaluru 5
Brasília 5
Hanoi 5
Hebei 5
Phoenix 5
Tianjin 5
Wuhan 5
Belo Horizonte 4
Bitonto 4
Brescia 4
Campinas 4
Casalgrande 4
Düsseldorf 4
Guangzhou 4
Kunming 4
Mons 4
Neviano degli Arduini 4
Norwalk 4
Padova 4
Rio de Janeiro 4
Salsomaggiore Terme 4
Soliera 4
Tashkent 4
Viamão 4
Alvignano 3
Brno 3
Buenos Aires 3
Buffalo 3
Cagliari 3
Castellarano 3
Totale 2.555
Salva come PNG Salva come JPEG
Nome #
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR 300
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines 210
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC) 198
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib 193
Dual inhibition of CDK4/6 and PI3K/AKT/mTOR signaling impairs energy metabolism in MPM cancer cells 170
Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer 168
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 166
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 160
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 154
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 139
CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells 130
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion 127
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN 127
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells (Frontiers in Oncology, (2022), 12, (942341), 10.3389/fonc.2022.942341) 121
INCREASED SOLUBLE AND MEMBRANE-BOUND PD-L1 EXPRESSION IN NSCLC CELL LINES TREATED WITH PEMETREXED 115
Biological hallmarks and new therapeutic approaches for the treatment of pdac 111
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines 107
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells 106
PD-L1 OVEREXPRESSION INDUCES ANGIOGENIC CYTOKINE SECRETION AND ENDOTHELIAL CELL MIGRATION VIA STAT SIGNALLING. 105
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells 105
Overcoming Palbociclib Resistance by Combined Treatment with PI3K/AKT/mTOR Inhibitors in Mesothelioma Cells 105
PD-L1 level is up-regulated in NSCLC cells after pemetrexed treatment 102
Circulating TGF-Beta and PD-L1 in Pancreatic Cancer 98
It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer 97
State of the art and perspectives in pediatric hepatocellular carcinoma 86
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines 84
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells 82
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 77
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 58
PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition 58
Correction to: Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer (Cancers, (2020), 12, 3, (666), 10.3390/cancers12030666) 45
Role of Cytokines and Other Soluble Factors in Tumor Development: Rationale for New Therapeutic Strategies 29
Correction to: The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells (Journal of Experimental & Clinical Cancer Research, (2018), 37, 1, (72), 10.1186/s13046-018-0741-3) 26
Totale 3.959
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.857
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021190 0 0 0 0 25 14 21 27 28 14 28 33
2021/2022176 22 13 24 8 3 3 28 4 11 8 8 44
2022/2023619 44 56 45 39 48 58 12 60 198 6 36 17
2023/2024390 14 23 21 14 48 56 33 25 12 32 55 57
2024/20251.050 38 40 60 70 101 110 114 69 107 92 102 147
2025/20261.056 182 213 349 218 94 0 0 0 0 0 0 0
Totale 3.959